All In Biotech

Free tool

FAERS Monitor: Aveed

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 022219 or its brand name (Aveed, Testosterone Undecanoate). Reports on generic versions are filed under their own applications.

Reports

1,547

Serious

970

63% of reports

Hospitalization

283

Death reported

51

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective231
  • cough153
  • off label use134
  • dyspnoea107
  • pulmonary oil microembolism84
  • blood testosterone decreased65
  • fatigue57
  • dizziness52
  • injection site pain52
  • hyperhidrosis48
  • asthenia47
  • malaise41
  • inappropriate schedule of drug administration36
  • inappropriate schedule of product administration36
  • chest pain32

Reports by year received

View as table
YearReports
20042
20051
20061
20093
20106
20112
20129
20135
2014120
2015232
2016142
201798
2018154
2019140
2020136
2021104
202276
202362
202441
2025132
202681

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,052,612 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
pulmonary oil microembolismSignal8449701.231420.8886,725
blood testosterone decreasedSignal65130.4102.78,144
coughSignal1537.46.4855
inappropriate schedule of drug administrationSignal366.95.0176
hyperhidrosisSignal485.13.8154
inappropriate schedule of product administrationSignal362.72.038
dyspnoeaSignal1072.62.1104
drug ineffectiveSignal2312.42.1196
chest painSignal322.31.724
injection site painSignal522.31.838
off label useSignal1342.11.877
asthenia471.71.313
dizziness521.41.16
malaise411.30.92
fatigue571.00.80

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.